Publications
Filters: Keyword is Primaquine [Clear All Filters]
“G6PD deficiency in malaria endemic areas of Nepal”, Malar J, vol. 19, no. 1, p. 287, 2020.
, “Optimizing G6PD testing for Plasmodium vivax case management: why sex, counseling, and community engagement matter”, Wellcome Open Res, vol. 5, p. 21, 2020.
, “Vivax malaria in pregnancy and lactation: a long way to health equity”, Malar J, vol. 19, no. 1, p. 40, 2020.
, “Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria”, Clin Infect Dis, vol. 68, no. 8, pp. 1311-1319, 2019.
, “Contribution of Asymptomatic Plasmodium Infections to the Transmission of Malaria in Kayin State, Myanmar”, J Infect Dis, vol. 219, no. 9, pp. 1499-1509, 2019.
, “The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis”, BMC Med, vol. 17, no. 1, p. 151, 2019.
, “The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis”, Wellcome Open Res, vol. 4, p. 25, 2019.
, , “Primaquine-induced haemolysis in females heterozygous for G6PD deficiency”, Malar J, vol. 17, no. 1, p. 101, 2018.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Management of relapsing Plasmodium vivax malaria”, Expert Rev Anti Infect Ther, 2016.
,